About IMI

Annual General Assembly Meeting – Berlin, Feb 2015

Home
Annual General Assembly Meeting – Berlin, Feb 2015

- 19 JAN 15
- 0 comments
Annual General Assembly Meeting – Berlin, Feb 2015

The PRECISESADS Consortium met for their first Annual General Assembly Meeting together with the External Scientific Advisory Board & Independent Ethical Advisory Board last February in Berlin. This important meeting allowed all partners to come together and share the achievements to date and validate next steps.
Leave a reply →
- Posted in
- News
- Posted by
- Tania

Photostream

Precisesads

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases

by phone: +34 958 715 500
by e-mail:
or fill in the form on contact page

IMI
European Union
EFPIA

This website reflects only the author’s views and neither IMI nor the European Commission are liable for any use that may be made of the information contained therein.

PRECISESADS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° [115565], resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.

PRECISESADS

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases

P. T. Ciencias de la Salud Avda. de la Ilustración 114

Telf. +34 958 715 500 (ext 202)
18016 Granada, Spain

Fax +34 958 637 071

Top

Annual General Assembly Meeting – Berlin, Feb 2015